Provided By GlobeNewswire
Last update: Nov 15, 2024
SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that management will participate in a presentation and fireside chat, and host one-on-one meetings at the Jefferies London Healthcare Conference being held November 19-21, 2024, in London, UK.
Read more at globenewswire.comNASDAQ:GPCR (6/10/2025, 10:44:11 AM)
20.8
+0.29 (+1.41%)
Find more stocks in the Stock Screener